Publications

Find at Harvard

Read Now

2016
Book

Innovation Policy and the Economy, Volume 17

By: Shane Greenstein, Josh Lerner and Scott Stern

The seventeenth volume of the National Bureau of Economic Research’s Innovation Policy and the Economy provides an accessible forum for bringing the work of leading academic researchers to an audience of policymakers and those interested in the interaction... View Details

Keywords: Innovation and Invention; Technological Innovation; Governance; Policy; Economy

06 Nov 2008
Working Paper Summaries

Extending Producer Responsibility: An Evaluation Framework for Product Take-Back Policies

Keywords: by Michael W. Toffel, Antoinette Stein & Katharine L. Lee; Chemical

ULI Report Provides Wildfire, Energy, and Economic Resilience Strategies to Sonoma County

Sonoma County, Calif., can enhance its ability to withstand and recover from wildfires by re-envisioning its land use, energy, and housing policies through a cooperative... View Details

March 2021 (Revised January 2023)
Case

The Trouble with TCE

By: Vincent Pons, Rafael Di Tella and Galit Goldstein

Trichloroethylene, or TCE, was a chemical used by tens of thousands of businesses in the United States. It was an affordable tool for many. Yet, TCE had been associated with important health risks, including cancer and autoimmune disease. TCE potentially posed other... View Details

Keywords: Trichloroethylene; Toxicity; Lobbying; Chemicals; Health Disorders; Governing Rules, Regulations, and Reforms; Policy; Ethics; Business and Government Relations; Chemical Industry; United States

April 1991 (Revised April 1992)
Case

Hospital Sector in 1992

Examines the major issues facing the hospital sector in 1992. The environment surrounding the industry is one of great uncertainty and rapid change, and involves significant public policy questions. Describes recent trends, issues and new types of competitors that... View Details

Keywords: Risk and Uncertainty; Nonprofit Organizations; Competition; Health Care and Treatment; Policy; Change; Health Industry; United States

Find at Harvard

June 2023
Case

Verve Therapeutics: Taking DNA Editing to Heart

By: Shikhar Ghosh and Shweta Bagai

Verve Therapeutics, a public biotech company based in Boston, created a novel approach to addressing cardiovascular disease (CVD) - a leading cause of deaths globally. The company's approach was a single shot treatment to permanently lower cholesterol, thus reducing... View Details

Keywords: AI; Genetic Engineering; Medicine; Health Care and Treatment; Genetics; Innovation Strategy; Business and Stakeholder Relations; Medical Specialties; Innovation and Invention; Entrepreneurship; Biotechnology Industry

Program

The Women's Leadership Forum

Attend This women's leadership development program is designed for women in senior leadership positions in public and private companies and nonprofit organizations, including senior executives, business owners and entrepreneurs, business... View Details

November 2001 (Revised September 2004)
Case

Evolution of Treatment, The: The Case of Diabetes

By: Richard M.J. Bohmer, Jeffrey D. Street and Laura Feldman

Scientific knowledge surrounding diabetes mellitus has grown over the last century to include its cause, treatment, and prevention strategies. However, the type and level of care that patients receive is suboptional. This case examines the forces in industry,... View Details

Keywords: Policy; Health Care and Treatment; Innovation and Management; Knowledge Use and Leverage; Management; Management Analysis, Tools, and Techniques; Health Industry

29 Jan 2019
First Look

New Research and Ideas, January 29, 2019

endowments, mergers, and limited liability. Publisher's link: https://www.hbs.edu/faculty/Pages/item.aspx?num=55499 January 2019 Health Affairs Decreases In Readmissions Credited to Medicare's Program to Reduce Hospital Readmissions Have... View Details

Keywords: Dina Gerdeman

March 2023 (Revised March 2023)
Case

Roche: Innovation and Access to Healthcare

By: George Serafeim, Susanna Gallani and Benjamin Maletta

In May 2022, Roche Group, one of the largest healthcare companies in the world, hosted its first investor event focused exclusively on its efforts to impact access to healthcare. While Roche had recently set an ambitious goal to double the number of patients that had... View Details

16 Aug 2024
In Practice

Election 2024: What's at Stake for Business and the Workplace?

vital infrastructure that keeps the economy—and goods and services—moving, including roads, bridges, ports, and freight trains. Businesses that want employees to return to the office know that commute times can depend on potholes and View Details

Keywords: by Rachel Layne

25 Jan 2013
Research & Ideas

Why a Harvard Finance Instructor Went to the Kumbh Mela

up here. Prof. Greg Greenough of the Harvard School of Public Health is directing researchers interested in everything from the pH of the Ganga to the quality and quantity of toilets to the structure of the... View Details

Keywords: by John D. Macomber; Construction; Real Estate

December 2021
Case

Pairwise

By: José B. Alvarez and Annelena Lobb

Pairwise discusses the strategic approach of a company aiming to “snackify” fruits and vegetables by using CRISPR-Cas9 gene editing to create nutritious, bite-sized foods that could compete with packaged snacks. The company is confronting a number of challenges,... View Details

Keywords: Gene Editing; GMO; Food; Nutrition; Competition; Market Entry and Exit; Public Opinion; Competitive Strategy; Consumer Behavior; Food and Beverage Industry

March 2012
Article

Reviving Entrepreneurship

By: Josh Lerner and William Sahlman

New enterprises don't exist in a vacuum: They rise or fall depending on myriad contextual factors, all of them interrelated, and all of them affected by government policy. U.S. lawmakers must carefully consider the effects of interventions in at least 12 areas, ranging... View Details

Keywords: Entrepreneurship; Government and Politics; Policy; Economy; Public Administration Industry; United States

Find at Harvard

2025
Working Paper

Why Most Resist AI Companions

By: Julian De Freitas, Zeliha Oğuz-Uğuralp, Ahmet Kaan Uğuralp and Stefano Puntoni

AI companion applications—designed to serve as synthetic interaction partners—have recently become capable enough to reduce loneliness, a growing public health concern. However, behavioral research has yet to fully explain the barriers to adoption of such AI and... View Details

Keywords: Generative Ai; Chatbots; Artificial Intelligence; Algorithmic Aversion; Lonelines; Technology Adoption; AI and Machine Learning; Well-being; Emotions